Evidence map›Paper›PMID 33573697›Full record

ReviewAntimicrobial resistance and infection control2021

A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India.

Sanjeev Singh, Esmita Charani, Sarada Devi, Anuj Sharma, Fabia Edathadathil, Anil Kumar, Anup Warrier, P S Shareek, A V Jaykrishnan, K Ellangovan

Abstract readReview
In one paragraph

Review in Antimicrobial resistance and infection control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Community pharmacists as antimicrobial resistance stewards: a narrative review on their contributions and challenges in low- and middle-income countries.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  17. Article
  18. Review
  19. The elephant in the room: Exploring the influence and participation of patients in infection-related care across surgical pathways in South Africa and India.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sanjeev SinghAmrita Institute of Medical Sciences, Amrita Vishwavidyapeetham, Kochi, India. sanjeevksingh@aims.amrita.edu.ORCID 0000-0002-0739-9988
Esmita CharaniNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College, London, UK.
Sarada DeviTrivandrum Medical College, Trivandrum, India.
Anuj SharmaTechnical Focal Point, Antimicrobial Resistance, Laboratory and Infection Prevention and Control, WHO Country Office, Delhi, India.
Fabia EdathadathilAmrita Institute of Medical Sciences, Amrita Vishwavidyapeetham, Kochi, India.
Anil KumarAmrita Institute of Medical Sciences, Amrita Vishwavidyapeetham, Kochi, India.
Anup WarrierAster Medcity Hospital, Kochi, India.
P S ShareekSree Uthradom Thirunal Hospital, Trivandrum, India.
A V JaykrishnanIndian Medical Association, Kochi, India.
K EllangovanMinistry of Health and Family Welfare, Government of Kerala, Trivandrum, India.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe global concern over antimicrobial resistance (AMR) is gathering pace. Low- and middle-income countries (LMICs) are at the epicentre of this growing public health threat and governmental and healthcare organizations are at different stages of implementing action plans to tackle AMR. The South Indian state of Kerala was one of the first in India to implement strategies and prioritize activities to address this public health threat. STRATEGIES: Through a committed and collaborative effort from all healthcare related disciplines and its professional societies from both public and private sector, the Kerala Public Private Partnership (PPP) has been able to deliver a state-wide strategy to tackle AMR A multilevel strategic leadership model and a multilevel implementation approach that included developing state-wide antibiotic clinical guidelines, a revision of post-graduate and undergraduate medical curriculum, and a training program covering all general practitioners within the state the PPP proved to be a successful model for ensuring state-wide implementation of an AMR action plan. Collaborative work of multi-professional groups ensured co-design and development of disease based clinical treatment guidelines and state-wide infection prevention policy. Knowledge exchange though international and national platforms in the form of workshops for sharing of best practices is critical to success. Capacity building at both public and private institutions included addressing practical and local solutions to the barriers e.g. good antibiotic prescription practices from primary to tertiary care facility and infection prevention at all levels.

conclusionThrough 7 years of stakeholder engagement, lobbying with government, and driving change through co-development and implementation, the PPP successfully delivered an antimicrobial stewardship plan across the state. The roadmap for the implementation of the Kerala PPP strategic AMR plan can provide learning for other states and countries aiming to implement action plans for AMR.

Indexed as

Antimicrobial StewardshipDeveloping CountriesDrug Resistance, BacterialPublic-Private Sector PartnershipsCurriculumEducation, MedicalIndiaPractice Guidelines as TopicAntimicrobial resistanceAntimicrobial stewardshipKARSAPKerala modelPublic private partnership

Identifiers

PMID33573697
PMCPMC7878026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.